Modified cued recall test in the French population with Down syndrome: A retrospective medical records analysis.

Background: Adults with Down syndrome (DS) are at increased risk of developing Alzheimer's disease (AD) due to genetic predisposition. Identification of patients with AD is difficult since intellectual disabilities (ID) may confound diagnosis. The objective of this study was to evaluate the ability...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Intellectual Disability Research Vol. 66; no. 8; pp. 690 - 704
Autores principales: Sacco, S., Falquero, S., Bouis, C., Akkaya, M., Gallard, J., Pichot, A., Radice, G., Bazin, F., Montestruc, F., Hiance‐Delahaye, A., Rebillat, A.‐S.
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Aug2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=158634356&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 158634356
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09642633
        EUL
      jtl: Journal of Intellectual Disability Research
      issn: 09642633
      maglogo: Y
    pubinfo:
      dt: Aug2022
      vid: 66
      iid: 8
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        158634356
        157537399
        158634356
        158634356
        10.1111/jir.12957
        158634356
      ppf: 690
      ppct: 14
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Modified cued recall test in the French population with Down syndrome: A retrospective medical records analysis.
      aug:
        au:
          Sacco, S.
          Falquero, S.
          Bouis, C.
          Akkaya, M.
          Gallard, J.
          Pichot, A.
          Radice, G.
          Bazin, F.
          Montestruc, F.
          Hiance‐Delahaye, A.
          Rebillat, A.‐S.
        affil: Institut Jérôme Lejeune, Paris, France
      sug:
        subj:
          Down Syndrome Complications
          Alzheimer's Disease Diagnosis
          Neuropsychological Tests
          Cues
          Clinical Assessment Tools Evaluation
          Instrument Validation
          Human
          Retrospective Design
          Male
          Female
          Adult
          Middle Age
          Descriptive Statistics
          Data Analysis Software
          Record Review
          Validation Studies
          Repeated Measures
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Background: Adults with Down syndrome (DS) are at increased risk of developing Alzheimer's disease (AD) due to genetic predisposition. Identification of patients with AD is difficult since intellectual disabilities (ID) may confound diagnosis. The objective of this study was to evaluate the ability of the French version of the modified cued recall test (mCRT) to distinguish between subjects with and without AD in the adult DS population. Methods: This was a retrospective, single‐centre, medical records study including data between March 2014 and July 2020. Adults aged ≥30 years with DS who had at least one mCRT record available were eligible. Age, sex and ID level were extracted, and subjects were attributed to three groups: patients with AD, patients with co‐occurring conditions that may impact cognitive function and subjects without AD. mCRT scores, adjusted by sex, age and ID level, were compared between groups. The optimal cut‐off value to distinguish between patients with and without AD was determined using the receiver operating characteristic curve. The impact of age and ID level on mCRT scores was assessed. Results: Overall, 194 patients with DS were included: 12 patients with AD, 94 patients with co‐occurring conditions and 88 healthy subjects. Total recall scores were significantly lower (P < 0.0001) in patients with AD compared with healthy subjects. The optimal cut‐off value to discriminate between patients with AD and healthy subjects was 22, which compares well with the cut‐off value of 23 originally reported for the English version of the mCRT. Patients aged 30–44 years had higher mCRT total recall scores compared with patients aged ≥45 years (P = 0.0221). Similarly, patients with mild ID had higher mCRT scores compared with patients with severe ID (P < 0.0001). Interpretation: The mCRT is a sensitive tool that may help in the clinical diagnosis of AD in subjects with DS. Early recognition of AD is paramount to deliver appropriate interventions to this vulnerable population.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N